ESG Report

Overview

The report presents Starpharma's four-pillar ESG framework covering Products & Patient Health, Our People, Governance and Environment. It highlights the company's proactive COVID-19 response, including safety measures for staff and trial participants and the rapid development and launch of VIRALEZE. It reports 40% female representation on the Board and approximately half of employees as female. The report also describes product quality, supplier conduct, anti-bribery, waste management and energy-reduction practices.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: Ends 30 June 2021
Language: English
Pages
File size

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services